IVIG IS OUR MIDDLE NAME Trademark

Trademark Overview

On Thursday, March 2, 2023, a trademark application was filed for IVIG IS OUR MIDDLE NAME with the United States Patent and Trademark Office. The USPTO has given the IVIG IS OUR MIDDLE NAME trademark a serial number of 97819809. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, April 1, 2024. This trademark is owned by CSL Behring AG. The IVIG IS OUR MIDDLE NAME trademark is filed in the Paper & Printed Material Products, Advertising, Business and Retail Services, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals

Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders

Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals

Providing a website featuring healthcare information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
ivig is our middle name

General Information

Serial Number97819809
Word MarkIVIG IS OUR MIDDLE NAME
Filing DateThursday, March 2, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements

Goods and ServicesHealthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
Goods and ServicesPrinted materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
Pseudo MarkINTRAVENOUS IMMUNOGLOBULIN IS OUR MIDDLE NAME
Goods and ServicesHealthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
Goods and ServicesProviding a website featuring healthcare information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
Disclaimer with Predetermined Text"IVIG"

Classification Information

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressBern 3014
CH
Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressBern 3014
CH

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2024SOU EXTENSION 1 GRANTED
Monday, April 1, 2024SOU EXTENSION 1 FILED
Monday, April 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 10, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 10, 2023NON-FINAL ACTION WRITTEN
Monday, April 17, 2023ASSIGNED TO EXAMINER
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023NEW APPLICATION ENTERED

Related Keywords

name middle ivig healthcare immunodeficiency disorders immunoglobulin neurological patients information caregivers namely treatment